Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
2.040
+0.080 (4.08%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Enveric Biosciences Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Enveric Biosciences in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Enveric Biosciences.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +5,782.35% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $1,800 | Strong Buy | Initiates | $1,800 | +88,135.29% | Jan 30, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $11,250 | Strong Buy | Initiates | $11,250 | +551,370.59% | Jun 1, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades $63,000 → $1,800 | Strong Buy → Hold | Downgrades | $63,000 → $1,800 | +88,135.29% | Mar 8, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates $63,000 | Strong Buy | Initiates | $63,000 | +3,088,135.29% | Jul 8, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.88
from -228.48
EPS Next Year
-1.79
from -0.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | n/a | n/a |
| Avg | n/a | n/a |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.90 | -1.84 |
| Avg | -0.88 | -1.79 |
| Low | -0.84 | -1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.